Publications by authors named "N L P Andrews"
Background: Disease severity and pregnancy outcomes following SARS-CoV-2 reinfections in pregnancy are not well understood.
Methods: We linked women aged 18 to 50 years testing positive in the community for COVID-19 between April 2021 and March 2022 to hospital, vaccine and maternal services databases. We compared hospital and intensive care unit (ICU) admission rates following infection and reinfection in pregnant and non-pregnant women, and low birthweight, prematurity and stillbirth in women infected and reinfected during pregnancy.
Article Synopsis
- The study investigates the safety and immunogenicity of a TdaP vaccine for pregnant women living with HIV, aiming to protect infants from severe pertussis disease.
- Conducted in Uganda, the trial randomly assigned 181 women (HIV-positive and HIV-negative) to receive either the TdaP or Td vaccine, evaluating immune responses in infants post-delivery.
- Findings will provide valuable insights into the vaccine's effectiveness and safety for this specific population, contributing to better health outcomes for mothers and their babies.
Objectives: How health and social care professionals need to work together to deliver advance care planning (ACP) in nursing homes is not fully understood, with a reliance on professionals external to the nursing home to support ACP in the United Kingdom. The objectives of this study were to (a) examine the factors that influence multi-professional involvement in the ACP process within nursing homes and (b) explore how multi-professional working impacts the ACP process in nursing homes.
Methods: Using ethnography, data was collected through observation, interviews and document review from 36 participants including residents ( = 6), relatives ( = 4), nursing home staff ( = 19) and visiting professionals ( = 7).
Article Synopsis
- Harm reduction for people who use drugs (PWUD) is a key strategy in US drug policy, focusing on meeting communities’ needs and providing various support services.
- The Block-by-Block (BXB) intervention, launched in 2022 across five pilot areas in Illinois, aims to distribute naloxone and drug test strips in private or neutral settings to reduce opioid-related fatalities.
- Early results show that the BXB initiative is feasible, with a 55% response rate at homes approached, and high acceptability, as 75% of those who answered were supportive of the intervention.